Therapeutic implications for overcoming radiation resistance in cancer therapy

Cited 197 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorB M Kim-
dc.contributor.authorY Hong-
dc.contributor.authorS Lee-
dc.contributor.authorP Liu-
dc.contributor.authorJ H Lim-
dc.contributor.authorY H Lee-
dc.contributor.authorT H Lee-
dc.contributor.authorKyu Tae Chang-
dc.contributor.authorY Hong-
dc.date.accessioned2017-04-19T10:14:21Z-
dc.date.available2017-04-19T10:14:21Z-
dc.date.issued2015-
dc.identifier.issn1422-0067-
dc.identifier.uri10.3390/ijms161125991ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/12980-
dc.description.abstractIonizing radiation (IR), such as X-rays and gamma (γ)-rays, mediates various forms of cancer cell death such as apoptosis, necrosis, autophagy, mitotic catastrophe, and senescence. Among them, apoptosis and mitotic catastrophe are the main mechanisms of IR action. DNA damage and genomic instability contribute to IR-induced cancer cell death. Although IR therapy may be curative in a number of cancer types, the resistance of cancer cells to radiation remains a major therapeutic problem. In this review, we describe the morphological and molecular aspects of various IR-induced types of cell death. We also discuss cytogenetic variations representative of IR-induced DNA damage and genomic instability. Most importantly, we focus on several pathways and their associated marker proteins responsible for cancer resistance and its therapeutic implications in terms of cancer cell death of various types and characteristics. Finally, we propose radiation-sensitization strategies, such as the modification of fractionation, inflammation, and hypoxia and the combined treatment, that can counteract the resistance of tumors to IR.-
dc.publisherMDPI-
dc.titleTherapeutic implications for overcoming radiation resistance in cancer therapy-
dc.title.alternativeTherapeutic implications for overcoming radiation resistance in cancer therapy-
dc.typeArticle-
dc.citation.titleInternational Journal of Molecular Sciences-
dc.citation.number11-
dc.citation.endPage26913-
dc.citation.startPage26880-
dc.citation.volume16-
dc.contributor.affiliatedAuthorKyu Tae Chang-
dc.contributor.alternativeName김병모-
dc.contributor.alternativeName홍윤경-
dc.contributor.alternativeName이승훈-
dc.contributor.alternativeNameLiu-
dc.contributor.alternativeName임지홍-
dc.contributor.alternativeName이용헌-
dc.contributor.alternativeName이태호-
dc.contributor.alternativeName장규태-
dc.contributor.alternativeName홍용은-
dc.identifier.bibliographicCitationInternational Journal of Molecular Sciences, vol. 16, no. 11, pp. 26880-26913-
dc.identifier.doi10.3390/ijms161125991-
dc.subject.keywordCancer therapy-
dc.subject.keywordCell death-
dc.subject.keywordDNA damage-
dc.subject.keywordIonizing radiation (IR)-
dc.subject.keywordPrognostic markers-
dc.subject.keywordResistance-
dc.subject.keywordTherapeutic targets-
dc.subject.localcancer therapy-
dc.subject.localCancer therapy-
dc.subject.localcell death-
dc.subject.localCell death-
dc.subject.localDNA damage-
dc.subject.localIonizing radiation-
dc.subject.localIonizing radiation (IR)-
dc.subject.localionizing radiation-
dc.subject.localPrognostic markers-
dc.subject.localprognostic marker-
dc.subject.localPrognostic marker-
dc.subject.localResistance-
dc.subject.localresistance-
dc.subject.localTherapeutic Targets-
dc.subject.localtherapeutic target-
dc.subject.localtherapeutic targets-
dc.subject.localTherapeutic target-
dc.subject.localTherapeutic targets-
dc.description.journalClassY-
Appears in Collections:
1. Journal Articles > Journal Articles
Files in This Item:

Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.